MAPT and Alzheimer disease: This in vivo study conducted on AD mouse model proved that the attenuation of insulin signaling is involved in an increase of toxic Aβ1-42 conformer levels which promotes not only an increase in p-Tau but also a direct interaction between the two misfolded proteins with the formation of their co-aggregates [67].